267 related articles for article (PubMed ID: 36260870)
21. MiRNA-144-5p down-modulates CDCA3 to regulate proliferation and apoptosis of lung adenocarcinoma cells.
Luo J; Xia L; Zhang L; Zhao K; Li C
Mutat Res; 2022; 825():111798. PubMed ID: 36087462
[TBL] [Abstract][Full Text] [Related]
22. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.
Petkova V; Marinova D; Kyurkchiyan S; Stancheva G; Mekov E; Kachakova-Yordanova D; Slavova Y; Kostadinov D; Mitev V; Kaneva R
Medicine (Baltimore); 2022 Aug; 101(33):e30027. PubMed ID: 35984198
[TBL] [Abstract][Full Text] [Related]
23. miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8.
Hu C; Wu J; Wang L; Liu X; Da B; Liu Y; Huang L; Chen Q; Tong Y; Jiang Z
Pathol Res Pract; 2021 Jul; 223():153459. PubMed ID: 33971546
[TBL] [Abstract][Full Text] [Related]
24. LncRNA-LINC01089 inhibits lung adenocarcinoma cell proliferation and promotes apoptosis via sponging miR-543.
Xu Y; Lin L; Lv D; Yan S; He S; Ge H
Tissue Cell; 2021 Oct; 72():101535. PubMed ID: 33892399
[TBL] [Abstract][Full Text] [Related]
25. Identifying and Validating a Novel miRNA-mRNA Regulatory Network Associated with Prognosis in Lung Adenocarcinoma.
Xu WQ; Ye JJ; Chen TB
Chin Med Sci J; 2022 Mar; 37(1):31-43. PubMed ID: 35531948
[TBL] [Abstract][Full Text] [Related]
26. miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis.
Zhu C; Wang S; Zheng M; Chen Z; Wang G; Ma J; Zhang B; Huang W; Sun X; Wang C
Strahlenther Onkol; 2022 Mar; 198(3):304-314. PubMed ID: 35037949
[TBL] [Abstract][Full Text] [Related]
27. Identification of the circRNA-miRNA-mRNA Prognostic Regulatory Network in Lung Adenocarcinoma.
Ma Y; Zou H
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627270
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive analysis of aberrantly expressed microRNA profiles reveals potential biomarkers of human lung adenocarcinoma progression.
Sui J; Yang RS; Xu SY; Zhang YQ; Li CY; Yang S; Yin LH; Pu YP; Liang GY
Oncol Rep; 2017 Oct; 38(4):2453-2463. PubMed ID: 28791371
[TBL] [Abstract][Full Text] [Related]
29. The clinical significance and mechanism of microRNA-22-3p targeting TP53 in lung adenocarcinoma.
Lin R; Li GS; Gan XY; Peng JX; Feng Y; Wang LT; Zhang CY; Huang KY; Huang SH; Yang L; Kong JL; Zhou HF; Chen G; Huang WY
Technol Health Care; 2023; 31(5):1691-1707. PubMed ID: 36970920
[TBL] [Abstract][Full Text] [Related]
30. Biomarker of Pulmonary Inflammatory Response in LUAD: miR-584-5p Targets RAB23 to Suppress Inflammation Induced by LPS in A549 Cells.
Yang E; Hong Y; Xuan C; Xu J; Ding Q; Zhao S; Ye H; Fan X; Jiang Z; Zhang S; Ding X
Protein Pept Lett; 2023; 30(10):877-890. PubMed ID: 38093594
[TBL] [Abstract][Full Text] [Related]
31. Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma.
Wu J; Feng Z; Wang R; Li A; Wang H; He X; Shen Z
Cancer Med; 2022 Dec; 11(23):4411-4421. PubMed ID: 35585716
[TBL] [Abstract][Full Text] [Related]
32. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
33. MiR-30a-3p Suppresses the Growth and Development of Lung Adenocarcinoma Cells Through Modulating GOLM1/JAK-STAT Signaling.
Ding D; Zhang Y; Zhang X; Shi K; Shang W; Ying J; Wang L; Chen Z; Hong H
Mol Biotechnol; 2022 Oct; 64(10):1143-1151. PubMed ID: 35438415
[TBL] [Abstract][Full Text] [Related]
34. A novel microRNA signature for pathological grading in lung adenocarcinoma based on TCGA and GEO data.
Yang Z; Yin H; Shi L; Qian X
Int J Mol Med; 2020 May; 45(5):1397-1408. PubMed ID: 32323746
[TBL] [Abstract][Full Text] [Related]
35. Microarray expression profile of microRNAs in lung adenocarcinoma patients with the Cancer Genome Atlas and its clinical validation.
Chen G; Xing Y; Peng X; Miao L; Zhao M; Zhou H; Xiao Y
J BUON; 2020; 25(2):821-827. PubMed ID: 32521873
[TBL] [Abstract][Full Text] [Related]
36. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
Feng H; Zhang Z; Qing X; French SW; Liu D
Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
[TBL] [Abstract][Full Text] [Related]
37. ANLN Regulated by miR-30a-5p Mediates Malignant Progression of Lung Adenocarcinoma.
Deng F; Xu Z; Zhou J; Zhang R; Gong X
Comput Math Methods Med; 2021; 2021():9549287. PubMed ID: 34777569
[TBL] [Abstract][Full Text] [Related]
38. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
[TBL] [Abstract][Full Text] [Related]
39. MiR-486-5p specifically suppresses SAPCD2 expression, which attenuates the aggressive phenotypes of lung adenocarcinoma cells.
Wei D
Histol Histopathol; 2022 Sep; 37(9):909-917. PubMed ID: 35467005
[TBL] [Abstract][Full Text] [Related]
40. circ_0000567/miR-421/
Hong Y; Si J; Xiao B; Xiong Y; Dai C; Yang Y; Li S; Ma Y
J Cancer; 2022; 13(5):1540-1552. PubMed ID: 35371319
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]